← Open Payments lookup

BRIAN KIMMEL: Open Payments

NPI 1528007176 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$505 in 23 payments from 11 companies in 2025. Trend: 2023 $431 · 2024 $390 · 2025 $505

Food & beverage: $505
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$98
PFIZER INC.4$76
AstraZeneca Pharmaceuticals LP4$74
ACADIA Pharmaceuticals Inc1$44
Bayer Healthcare Pharmaceuticals Inc.2$43
Aimmune Therapeutics, Inc.2$35
Dexcom, Inc.1$33
Lundbeck LLC1$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Exact Sciences Corporation1$25

Products named: REXULTI, FARXIGA, NUPLAZID, Kerendia, PAXLOVID, NURTEC ODT, Dexcom G6 Transmitter, CAPLYTA.

Industry payments across PA — which companies pay providers there.